Somnomed Ltd
ASX:SOM
Somnomed Ltd
Cash from Financing Activities
Somnomed Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Somnomed Ltd
ASX:SOM
|
Cash from Financing Activities
AU$6.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
250%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Financing Activities
AU$28m
|
CAGR 3-Years
3%
|
CAGR 5-Years
192%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
2%
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$377.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-21%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$2.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Cash from Financing Activities?
Cash from Financing Activities
6.3m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Cash from Financing Activities amounts to 6.3m AUD.
What is Somnomed Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-8%
Over the last year, the Cash from Financing Activities growth was -46%. The average annual Cash from Financing Activities growth rates for Somnomed Ltd have been -19% over the past three years , -8% over the past five years .